share_log

JP Morgan Downgrades Pacific Biosciences to Neutral

Moomoo 24/7 ·  Apr 22 08:20

JP Morgan analyst Rachel Vatnsdal downgrades Pacific Biosciences (NASDAQ:PACB) from Overweight to Neutral.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment